IMNN Celsion Corporation Price Chart

The price trend for Imunon, Inc. (IMNN) shown below reflects the dynamics of an asset valued at 0.63. Imunon, Inc. (IMNN) is implementing automated dosing systems and test analysis software. The business relies on the Theraiva platform for the targeted delivery of cancer drugs. However, potential failures in late-stage trials, liquidity shortages, and strict safety oversight of methods pose serious threats.

Share Price: imunon.com (IMNN) for 04/28/2023 - 11/14/2026

Celsion Corporation (IMNN) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Price Imunon, Inc.|IMNN - Analyst Median Target

- market capitalization data:

Market Value Imunon Inc|IMNN - Real Price to Acquire Entire Company

- balance sheet equity data:

Net Assets per Single Share Imunon|IMNN - Accounting Capitalization|Market Value to Book Value Ratio imunon.com|IMNN - Total Business Assets

- issuer credit burden and liquidity indicators:

- company profitability and valuation multiples indicators:

IMNN - Net Income|Future Profit Imunon, Inc.|IMNN - P/E Multiple|Future Price to Earnings Imunon, Inc.|IMNN - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Imunon Inc|IMNN - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Imunon|IMNN - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months imunon.com|IMNN - Earnings per share increase in current year|Earnings growth forecast for next year Imunon, Inc.

- sales revenue and business income indicators:

IMNN - Company Gross Revenue|Company Projected Revenue Imunon, Inc.|IMNN - Market Cap to Revenue Ratio|Forward P/S Multiple Imunon Inc

Summary company analytics:Imunon

The price reflects the market capitalization of investor expectations regarding future cash flows, capturing the business value through the mechanism of continuous supply and demand. By correlating current price action with operational results, an analyst determines the fairness of the valuation of Imunon, Inc. (IMNN), where price stability confirms market confidence in the company's adherence to strict biosafety standards during plasmid DNA production.

Analysis of competing companies